Sole Source Procurement for MyCare Psychiatry Clozapine Assay Kit and Controls from Saladax Biomedic

Summary (Newest Update)

Background The Oregon State Hospital, part of the Oregon Health Authority (OHA), is seeking to procure the MyCare Psychiatry Clozapine Assay Kit and Controls from Saladax Biomedical. This procurement is justified as a sole source due to the unique capabilities of the product and its compatibility with existing equipment at the agency. The MyCare Psychiatry Clozapine Assay Kit is an FDA-cleared immunoassay designed for rapid measurement of clozapine levels in human serum and plasma, which aids in patient therapy optimization. Saladax Biomedical is identified as the only supplier of this specific assay kit, essential for monitoring patient adherence. Work Details The contract involves the purchase of the MyCare Psychiatry Clozapine Assay Kit and Controls from Saladax Biomedical. The kit includes reagent kits, controls, and linearity materials necessary for conducting clozapine testing. The agency owns a Siemens Atellica CI 1900 Analyzer that is compatible with these assay kits. The estimated total contract value is $25,000 per year. Period of Performance The agency reserves the right to purchase additional goods and services related to assay support, quality control material, linearity material, and training for a period of 10 years from the date of the Sole Source Notice. Place of Performance The products will be delivered to the Oregon State Hospital located in Oregon. Bidder Requirements Saladax Biomedical is identified as the sole supplier for this procurement; no other vendors are authorized to supply these specific assay kits. There are no stated set-aside certifications or additional bidder requirements mentioned.